Literature DB >> 8240522

Prognostic value of the S-phase fraction of breast cancer.

Y Remvikos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8240522      PMCID： PMC1968557          DOI： 10.1038/bjc.1993.355

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  16 in total

1.  Breast cancer prognostic factors: evaluation guidelines.

Authors:  W L McGuire
Journal:  J Natl Cancer Inst       Date:  1991-02-06       Impact factor: 13.506

2.  Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. II. DNA flow cytometry changes during chemotherapy, tumor regression, and short-term follow-up.

Authors:  F Spyratos; M Briffod; M Tubiana-Hulin; C Andrieu; C Mayras; C Pallud; S Lasry; J Rouëssé
Journal:  Cancer       Date:  1992-01-15       Impact factor: 6.860

Review 3.  Predictive assays of tumor radiocurability.

Authors:  L J Peters; W A Brock; J D Chapman; G Wilson
Journal:  Am J Clin Oncol       Date:  1988-06       Impact factor: 2.339

4.  The DNA labelling index: a prognostic factor in node-negative breast cancer.

Authors:  M Héry; J Gioanni; C M Lalanne; M Namer; A Courdi
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

5.  Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy.

Authors:  Y Remvikos; P Beuzeboc; A Zajdela; N Voillemot; H Magdelénat; P Pouillart
Journal:  J Natl Cancer Inst       Date:  1989-09-20       Impact factor: 13.506

6.  Cell kinetics as a prognostic indicator in node-negative breast cancer.

Authors:  R Silvestrini; M G Daidone; P Valagussa; G Di Fronzo; G Mezzanotte; G Bonadonna
Journal:  Eur J Cancer Clin Oncol       Date:  1989-08

7.  Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma.

Authors:  J S Meyer
Journal:  NCI Monogr       Date:  1986

8.  Growth rate, kinetics of tumor cell proliferation and long-term outcome in human breast cancer.

Authors:  M Tubiana; M H Pejovic; S Koscielny; N Chavaudra; E Malaise
Journal:  Int J Cancer       Date:  1989-07-15       Impact factor: 7.396

9.  Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis.

Authors:  Y Remvikos; M Gerbault-Seureau; H Magdelénat; M Prieur; B Dutrillaux
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

10.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640
View more
  2 in total

1.  Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer.

Authors:  J Y Pierga; A Leroyer; P Viehl; V Mosseri; S Chevillard; H Magdelénat
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer.

Authors:  J Y Pierga; C Lainé-Bidron; P Beuzeboc; P De Crémoux; P Pouillart; H Magdelénat
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.